Hungary
ChemPass Kft is a Hungarian startup that utilizes AI to facilitate the discovery of patentable leads for therapeutic targets with its SynSpace software. Founded in 2016, the company focuses on developing AI-assisted technologies for exploration in synthesizable chemical space. ChemPass's SynSpace software has been designed to provide user-friendly solutions for synthetic medicinal chemists, computational chemists, and project leaders. It offers instant suggestions for novel analog design in lead optimization cycles and novel templates for lead finding or lead hopping. The company's generative design technologies have shown superior results compared to state-of-the-art deep learning techniques.
Another pioneering offering from ChemPass is the AID platform, which aims to revolutionize lead discovery. The components of this platform have been validated in numerous collaborative projects, underpinning its potential for significant impact in the industry. The startup's expertise lies in the biotechnology and information technology sectors.
At the most recent funding round in August 29, 2018, ChemPass secured a €129.00K Seed Round investment from Hiventures, showcasing confidence from the investment community in the company's innovative approach and potential for growth. With its unique approach to AI-assisted lead discovery and strong backing from investors, ChemPass Kft is poised to make a meaningful impact in the biotechnology and information technology landscapes.
